Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AKBA
EYPT
Add up to 3 more stocks
AKBA
Akebia Therapeutics, Inc.
-3.51%
$0.88-0.03Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$235.66M
52W Range
$0.81 - $3.20
EYPT
EyePoint Pharmaceuticals, Inc.
+0.63%
$3.17+0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$265.78M
52W Range
$3.05 - $19.11
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 9.42 | 1.60 |
| P/S Ratio | 1.08 | 95.29 |
| P/FCF Ratio | 5.87 | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.5% | 93.4% |
| Operating Margin | 9.9% | -776.0% |
| Net Margin | -13.5% | -10994.7% |
| ROE | -118.6% | -184.3% |
| ROA | -8.5% | -134.4% |
| ROIC | -7.1% | -170.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.43 | 4.50 |
| Quick Ratio | 1.35 | 4.46 |
| Debt/Equity | 2.16 | 0.13 |
| Interest Coverage | 0.97 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.